Advertisement

Topics

Replicon Corporate Finance Oy/Ltd Company Profile

00:17 EST 11th December 2018 | BioPortfolio

Replicon is privately held, independent investment banking service company located in Helsinki, Finland. We provide first-class corporate finance and strategic advisory to our clients. Our range of expertise covers e.g. private equity transactions, M&A advisory, project financing and valuation services. We also provide financial and strategic consulting when related to financial arrangements or re-structuring.

Location

Aleksanterinkatu 17, 4th floorP.O. Box 800
Helsinki
FIN-00101
Finland

Contact

Phone: 358 (0)9 677 464
Fax: 358 9 677 464
Email: info@replicon.fi


News Articles [522 Associated News Articles listed on BioPortfolio]

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon

Clinical Finance: The Most Precious Of The Necessary Evils

Clinical Informatics News | Clinical finance can sometimes be viewed as a necessary evil. Chris Chan, Executive Director, R&D Finance, at Fibrogen, discusses how clinical finance can improve ...

Virbac: Availability_Half-yearly financial report_June 2018_Erratum

Virbac: Availability of the half-yearly financial report as of June 30, 2018 _ Erratum Public release - September 21, 2018 The sales breakdown table on page 3 of the half-year financial ...

Virbac: Availability of the half-yearly financial report as of June 30, 2018

Virbac: Availability of the half-yearly financial report as of June 30, 2018 Public release - September 17, 2018 Virbac announced today that the 2018 half-yearly financial report is now a...

Gene Replacement in Tomato, Achieved Using CRISPR-Cas9 and Replicon

CRISPR-Cas9 can be used to produce two types of gene edits, namely NHEJ and HDR repairs. The NHEJ repair is done by allowing the natural repairing system of the cells inside the plant to create new co...

#jobs #lifescience Manager of Finance and Accounting

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Manager of Finance and Accounting .MA-Boston, INDAF16 Manager of Finance and ...

#jobs #lifescience Senior Accountant – FP&A, Strategic Finance

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Accountant – FP&A, Strategic Finance .MA-Cambridge, Senior ...

#jobs #lifescience Sr. Manager, Finance & Administration

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sr. Manager, Finance & Administration .IN-Strawtown, SR. MANAGER, FINANC...

PubMed Articles [39 Associated PubMed Articles listed on BioPortfolio]

Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication.

The hepatitis C virus (HCV) subgenomic replicon is a valuable tool for studying virus replication and HCV drug development. Despite the fact that HCV genotype 1a (HCV1a) is the most prevalent genotype...

The dominance of finance in healthcare: political action of unlimited capital in the 21st century.

This article gives, first, a historical account of the action of capital in healthcare in contemporary Brazil and then introduces a debate on the dominance of finance ('financial dominance') in health...

Public-private partnerships in practice: collaborating to improve health finance policy in Ghana and Kenya.

The Economic Transition of Health in Africa: A Call for Progressive Pragmatism to Shape the Future of Health Financing.

Abstract-The new financing landscape for the Sustainable Development Goals has a larger emphasis on domestic resource mobilization. But, given the significant role of donor assistance for health, the ...

Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.

To elucidate HIV-1 co-infection-induced acceleration of HCV liver disease and identify stage-specific molecular signatures, we applied a new high-resolution molecular screen, the Affymetrix GeneChip H...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

AVX601, a bivalent alphavirus replicon vaccine expressing three CMV proteins (gB, pp65 and IE1) is a candidate vaccine against cytomegalovirus (CMV). The objectives of this Phase 1 study ...

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

AVX502, an alphavirus replicon vaccine expressing an influenza HA protein, is a candidate vaccine against influenza. The objectives of this Phase 1 study are to test the safety of the vac...

Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV

The high rates of HIV infection in women have brought into sharp focus the problem of violence against women. There is a growing recognition that women and girls' risk of and vulnerability...

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

The purpose of this study is to evaluate the safety of and immune response to an alphavirus replicon, HIV-1 subtype C gag vaccine, AVX101, in HIV uninfected adults in the United States, So...

The Influence of Significant Weight Lost on the Quality of Voice

The rate of obesity and bariatric surgery is rising steadily. Though Bariatric Surgery Influences on aspects such as endocrin analysis, finance, etc are well tested, quantitative and quali...

Companies [464 Associated Companies listed on BioPortfolio]

Replicon Corporate Finance Oy/Ltd

Replicon is privately held, independent investment banking service company located in Helsinki, Finland. We provide first-class corporate finance and strategic advisory to our clients. Our range of ex...

B. Riley & Co., LLC

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institution...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

International Business Forum

IBF – International Business Forum presents financial and business conferences on venture capital, corporate finance, mergers & acquisitions, corporate strategic investing, defined contribution/401(...

Replicon Technologies Incorporated

Replicon Technologies, Inc. (RTI) is an emerging biotechnology company focused on the use of replicons, non-replicating RNA viral particles, for the treatment of patients with cancer. RTI is founded ...

More Information about "Replicon Corporate Finance Oy/Ltd" on BioPortfolio

We have published hundreds of Replicon Corporate Finance Oy/Ltd news stories on BioPortfolio along with dozens of Replicon Corporate Finance Oy/Ltd Clinical Trials and PubMed Articles about Replicon Corporate Finance Oy/Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Replicon Corporate Finance Oy/Ltd Companies in our database. You can also find out about relevant Replicon Corporate Finance Oy/Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record